Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT00241553
Registration number
NCT00241553
Ethics application status
Date submitted
18/10/2005
Date registered
19/10/2005
Date last updated
24/01/2011
Titles & IDs
Public title
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Query!
Scientific title
Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs
Query!
Secondary ID [1]
0
0
SH-NEN-0004
Query!
Secondary ID [2]
0
0
D9617C00004
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
NSAIDs
0
0
Query!
Upper GI Symptoms
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
To assess the efficacy of esomeprazole versus placebo through 6 months of treatment for the prevention of relapse of upper GI symptom associated with NSAID use
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Secondary outcome [1]
0
0
To assess the safety & tolerability of esomeprazole versus placebo when administered for 6 months to patients receiving daily NSAID therapy.
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Eligibility
Key inclusion criteria
* Signed informed consent.
* Completed the SH-NEN-0003 study with relief of upper GI symptom. Relief is defined as "last 7 days with a diary assessment of None or Minimal, but allowing up to 2 days to be rated as Mild during the 7-day period".
* A clinical diagnosis of a chronic condition (e.g., osteoarthritis or rheumatoid arthritis) that requires continuous daily NSAID treatment for at least 6 months. Daily NSAID treatment is defined as taking the prescribed dose for at least 5 of 7 days in any given week and can include COX-2 selective NSAIDs, multiple NSAIDs, and high-dose NSAIDs.
* Daily NSAID treatment dose and type:
* Must have been stable for at least 9 weeks prior to inclusion
* Are expected to remain stable for the duration of the study.
* Must be administered orally. If more than one type of NSAID treatment is used, at least one type must be administered orally.
* Hp negative on Histology performed at baseline endoscopy in the study SHNEN-0003.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Discontinuation from study SH-NEN-0003
* Pain, discomfort or burning in the upper abdomen precipitated by exercise or relieved by defecation.
* Pain, discomfort or burning in the upper abdomen not associated with the use of NSAIDs, including COX-2 selective NSAIDs.
* Pregnancy or lactation. Women of childbearing potential must maintain effective contraception during the study period as judged by the investigator.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/04/2001
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/02/2003
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC
Query!
Recruitment hospital [1]
0
0
Research Site - Five Dock
Query!
Recruitment hospital [2]
0
0
Research Site - Various Cities
Query!
Recruitment hospital [3]
0
0
Research Site - Carina Heights
Query!
Recruitment hospital [4]
0
0
Research Site - Kippa Ring
Query!
Recruitment hospital [5]
0
0
Research Site - Ivanhoe
Query!
Recruitment postcode(s) [1]
0
0
- Five Dock
Query!
Recruitment postcode(s) [2]
0
0
- Various Cities
Query!
Recruitment postcode(s) [3]
0
0
- Carina Heights
Query!
Recruitment postcode(s) [4]
0
0
- Kippa Ring
Query!
Recruitment postcode(s) [5]
0
0
- Ivanhoe
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
California
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Florida
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Idaho
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Indiana
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Kansas
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Maryland
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Montana
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
New Jersey
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
New York
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
North Carolina
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Pennsylvania
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Tennessee
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Texas
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Washington
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Wisconsin
Query!
Country [18]
0
0
Canada
Query!
State/province [18]
0
0
Alberta
Query!
Country [19]
0
0
Canada
Query!
State/province [19]
0
0
British Columbia
Query!
Country [20]
0
0
Canada
Query!
State/province [20]
0
0
Manitoba
Query!
Country [21]
0
0
Canada
Query!
State/province [21]
0
0
Newfoundland and Labrador
Query!
Country [22]
0
0
Canada
Query!
State/province [22]
0
0
Ontario
Query!
Country [23]
0
0
Canada
Query!
State/province [23]
0
0
Quebec
Query!
Country [24]
0
0
Canada
Query!
State/province [24]
0
0
Saskatchewan
Query!
Country [25]
0
0
Czech Republic
Query!
State/province [25]
0
0
Hlu¿ín
Query!
Country [26]
0
0
Czech Republic
Query!
State/province [26]
0
0
Ostrava - T¿ebovice
Query!
Country [27]
0
0
Czech Republic
Query!
State/province [27]
0
0
Ostrava
Query!
Country [28]
0
0
Czech Republic
Query!
State/province [28]
0
0
Praha 2
Query!
Country [29]
0
0
Czech Republic
Query!
State/province [29]
0
0
Praha 5
Query!
Country [30]
0
0
Italy
Query!
State/province [30]
0
0
BA
Query!
Country [31]
0
0
Italy
Query!
State/province [31]
0
0
GE
Query!
Country [32]
0
0
Italy
Query!
State/province [32]
0
0
MI
Query!
Country [33]
0
0
Italy
Query!
State/province [33]
0
0
VI
Query!
Country [34]
0
0
Italy
Query!
State/province [34]
0
0
Napoli
Query!
Country [35]
0
0
Italy
Query!
State/province [35]
0
0
Parma
Query!
Country [36]
0
0
Italy
Query!
State/province [36]
0
0
Perugia
Query!
Country [37]
0
0
Italy
Query!
State/province [37]
0
0
Verona
Query!
Country [38]
0
0
Norway
Query!
State/province [38]
0
0
Bergen
Query!
Country [39]
0
0
Norway
Query!
State/province [39]
0
0
Bodø
Query!
Country [40]
0
0
Norway
Query!
State/province [40]
0
0
Bærum postterminal
Query!
Country [41]
0
0
Norway
Query!
State/province [41]
0
0
Gjøvik
Query!
Country [42]
0
0
Norway
Query!
State/province [42]
0
0
Horten
Query!
Country [43]
0
0
Norway
Query!
State/province [43]
0
0
Lillehammer
Query!
Country [44]
0
0
Norway
Query!
State/province [44]
0
0
Nesttun
Query!
Country [45]
0
0
Norway
Query!
State/province [45]
0
0
Oslo
Query!
Country [46]
0
0
Norway
Query!
State/province [46]
0
0
Sandvika
Query!
Country [47]
0
0
Norway
Query!
State/province [47]
0
0
Skien
Query!
Country [48]
0
0
Norway
Query!
State/province [48]
0
0
Stavanger
Query!
Country [49]
0
0
Norway
Query!
State/province [49]
0
0
Tromsø
Query!
Country [50]
0
0
Poland
Query!
State/province [50]
0
0
Bia¿ystok
Query!
Country [51]
0
0
Poland
Query!
State/province [51]
0
0
Bydgoszcz
Query!
Country [52]
0
0
Poland
Query!
State/province [52]
0
0
Sopot
Query!
Country [53]
0
0
Poland
Query!
State/province [53]
0
0
Warszawa
Query!
Country [54]
0
0
Poland
Query!
State/province [54]
0
0
Wrze¿nia
Query!
Country [55]
0
0
Slovakia
Query!
State/province [55]
0
0
Bratislava
Query!
Country [56]
0
0
Slovakia
Query!
State/province [56]
0
0
Nové Mesto nad Váhom
Query!
Country [57]
0
0
Slovakia
Query!
State/province [57]
0
0
Pie¿¿any
Query!
Country [58]
0
0
South Africa
Query!
State/province [58]
0
0
Bloemfontein
Query!
Country [59]
0
0
South Africa
Query!
State/province [59]
0
0
Cape Town
Query!
Country [60]
0
0
South Africa
Query!
State/province [60]
0
0
Johannesburg
Query!
Country [61]
0
0
Sweden
Query!
State/province [61]
0
0
Bredbyn
Query!
Country [62]
0
0
Sweden
Query!
State/province [62]
0
0
Gävle
Query!
Country [63]
0
0
Sweden
Query!
State/province [63]
0
0
Karlskrona
Query!
Country [64]
0
0
Sweden
Query!
State/province [64]
0
0
Kungälv
Query!
Country [65]
0
0
Sweden
Query!
State/province [65]
0
0
Lidköping
Query!
Country [66]
0
0
Sweden
Query!
State/province [66]
0
0
Malmö
Query!
Country [67]
0
0
Sweden
Query!
State/province [67]
0
0
Oskarshamn
Query!
Country [68]
0
0
Sweden
Query!
State/province [68]
0
0
Rättvik
Query!
Country [69]
0
0
Sweden
Query!
State/province [69]
0
0
Skövde
Query!
Country [70]
0
0
Sweden
Query!
State/province [70]
0
0
Stockholm
Query!
Country [71]
0
0
Sweden
Query!
State/province [71]
0
0
Trehörningsjö
Query!
Country [72]
0
0
Sweden
Query!
State/province [72]
0
0
Trollhättan
Query!
Country [73]
0
0
Sweden
Query!
State/province [73]
0
0
Varberg
Query!
Country [74]
0
0
Sweden
Query!
State/province [74]
0
0
Värnamo
Query!
Country [75]
0
0
Sweden
Query!
State/province [75]
0
0
Västervik
Query!
Country [76]
0
0
Sweden
Query!
State/province [76]
0
0
Örnsköldsvik
Query!
Country [77]
0
0
Sweden
Query!
State/province [77]
0
0
Östersund
Query!
Country [78]
0
0
United Kingdom
Query!
State/province [78]
0
0
Berks
Query!
Country [79]
0
0
United Kingdom
Query!
State/province [79]
0
0
Co. Durham
Query!
Country [80]
0
0
United Kingdom
Query!
State/province [80]
0
0
Surrey
Query!
Country [81]
0
0
United Kingdom
Query!
State/province [81]
0
0
Wiltshire
Query!
Country [82]
0
0
United Kingdom
Query!
State/province [82]
0
0
Ashford
Query!
Country [83]
0
0
United Kingdom
Query!
State/province [83]
0
0
Audley
Query!
Country [84]
0
0
United Kingdom
Query!
State/province [84]
0
0
Bath
Query!
Country [85]
0
0
United Kingdom
Query!
State/province [85]
0
0
Bradford upon Avon
Query!
Country [86]
0
0
United Kingdom
Query!
State/province [86]
0
0
Chesterfield
Query!
Country [87]
0
0
United Kingdom
Query!
State/province [87]
0
0
Coventry
Query!
Country [88]
0
0
United Kingdom
Query!
State/province [88]
0
0
Crawley
Query!
Country [89]
0
0
United Kingdom
Query!
State/province [89]
0
0
Ely
Query!
Country [90]
0
0
United Kingdom
Query!
State/province [90]
0
0
Folkestone
Query!
Country [91]
0
0
United Kingdom
Query!
State/province [91]
0
0
Glasgow
Query!
Country [92]
0
0
United Kingdom
Query!
State/province [92]
0
0
Kilmarnock
Query!
Country [93]
0
0
United Kingdom
Query!
State/province [93]
0
0
Leigh
Query!
Country [94]
0
0
United Kingdom
Query!
State/province [94]
0
0
Mansfield
Query!
Country [95]
0
0
United Kingdom
Query!
State/province [95]
0
0
Nottingham
Query!
Country [96]
0
0
United Kingdom
Query!
State/province [96]
0
0
Pontefract
Query!
Country [97]
0
0
United Kingdom
Query!
State/province [97]
0
0
Shrewsbury
Query!
Country [98]
0
0
United Kingdom
Query!
State/province [98]
0
0
Stafford
Query!
Country [99]
0
0
United Kingdom
Query!
State/province [99]
0
0
Swansea
Query!
Country [100]
0
0
United Kingdom
Query!
State/province [100]
0
0
Trowbridge
Query!
Country [101]
0
0
United Kingdom
Query!
State/province [101]
0
0
Tunbridge Wells
Query!
Country [102]
0
0
United Kingdom
Query!
State/province [102]
0
0
Watford
Query!
Country [103]
0
0
United Kingdom
Query!
State/province [103]
0
0
Wigston
Query!
Country [104]
0
0
United Kingdom
Query!
State/province [104]
0
0
Woking
Query!
Country [105]
0
0
United Kingdom
Query!
State/province [105]
0
0
Worsley
Query!
Country [106]
0
0
United Kingdom
Query!
State/province [106]
0
0
Yoxall
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
AstraZeneca
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This study was a multicentre, double-blind, randomised, placebo-controlled parallel group study consisting of 4 visits over a period of 6 months. The primary variable was to assess theefficacy of esomeprazole 40 mg orally qd (E40) or esomeprazole 20 mg orally qd (E20) versus placebo orally qd after 6 months of treatment for the prevention of relapse of upper GI symptoms associated with NSAID use, including COX-2 selective NSAIDs, in patients receiving daily NSAID therapy.
Query!
Trial website
https://clinicaltrials.gov/study/NCT00241553
Query!
Trial related presentations / publications
Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Langstrom G, Naesdal J, Yeomans ND; NASA/SPACE author group. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther. 2007;9(1):R17. doi: 10.1186/ar2124.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
AstraZeneca Nexium Medical Sciences Director, MD
Query!
Address
0
0
AstraZeneca
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT00241553
Download to PDF